Resveratrol attenuates efavirenz-induced hepatic steatosis and hypercholesterolemia in mice by inhibiting pregnane X receptor activation and decreasing inflammation
出版年份 2023 全文链接
标题
Resveratrol attenuates efavirenz-induced hepatic steatosis and hypercholesterolemia in mice by inhibiting pregnane X receptor activation and decreasing inflammation
作者
关键词
-
出版物
NUTRITION RESEARCH
Volume 119, Issue -, Pages 119-131
出版商
Elsevier BV
发表日期
2023-09-18
DOI
10.1016/j.nutres.2023.09.006
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Weight and Metabolic Outcomes in Naïve HIV Patients Treated with Integrase Inhibitor-Based Antiretroviral Therapy: A Systematic Review and Meta-Analysis
- (2023) German Valenzuela-Rodriguez et al. Journal of Clinical Medicine
- Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir
- (2023) Supphachoke Khemla et al. Drug Target Insights
- Phytochemicals for the treatment of metabolic diseases: Evidence from clinical studies
- (2023) Yuting Luo et al. BIOMEDICINE & PHARMACOTHERAPY
- Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
- (2022) Yongin Cho et al. BMC Medicine
- Pulmonary delivery of resveratrol-β-cyclodextrin inclusion complexes for the prevention of zinc chloride smoke-induced acute lung injury
- (2022) Wanmei Wang et al. DRUG DELIVERY
- Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis
- (2022) Chuangen Li et al. GUT
- A community based cross sectional study on the prevalence of dyslipidemias and 10 years cardiovascular risk scores in adults in Asmara, Eritrea
- (2022) Oliver Okoth Achila et al. Scientific Reports
- Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway
- (2022) Bin Jiang et al. Molecular Metabolism
- LDL Cholesterol Reduction Variability with Different Types and Doses of Statins in Monotherapy or Combined with Ezetimibe. Results from the Spanish Arteriosclerosis Society Dyslipidaemia Registry
- (2021) Elisenda Climent et al. CARDIOVASCULAR DRUGS AND THERAPY
- Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
- (2021) Fan Du et al. Frontiers in Microbiology
- Construction of Glycogen-Based Nanoparticles Loaded with Resveratrol for the Alleviation of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease
- (2021) Xiang Li et al. BIOMACROMOLECULES
- Dietary phytochemicals as modulators of human pregnane X receptor
- (2021) Jie Zhang et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Resveratrol and its derivative pterostilbene attenuate oxidative stress-induced intestinal injury by improving mitochondrial redox homeostasis and function via SIRT1 signaling
- (2021) Yanan Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Polyphenols and neuroprotection: Therapeutic implications for cognitive decline
- (2021) Giuseppe Caruso et al. PHARMACOLOGY & THERAPEUTICS
- Gradual increasing dyslipidemia in treatment-naive male patients with human immunodeficiency virus and treated with tenofovir plus lamivudine plus efavirenz for 3 years
- (2021) Dafeng Liu et al. Diabetology & Metabolic Syndrome
- Adverse events in Chinese human immunodeficiency virus (HIV) patients receiving first line antiretroviral therapy
- (2020) Lili Dai et al. BMC INFECTIOUS DISEASES
- Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy
- (2020) Anait S. Levenson SEMINARS IN CANCER BIOLOGY
- Real-life management of drug–drug interactions between antiretrovirals and statins
- (2020) Perrine Courlet et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Resveratrol Alleviates Endoplasmic Reticulum Stress–Associated Hepatic Steatosis and Injury in Mice Challenged with Tunicamycin
- (2020) Yanan Chen et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis
- (2019) Taesik Gwag et al. JOURNAL OF HEPATOLOGY
- Sesamin, a Naturally Occurring Lignan, Inhibits Ligand-Induced Lipogenesis through Interaction with Liver X Receptor Alpha (LXRα) and Pregnane X Receptor (PXR)
- (2019) Tsai-Sung Tai et al. Evidence-based Complementary and Alternative Medicine
- Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production
- (2017) Zhenhua Ma et al. PLoS One
- Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy
- (2015) Kristine M. Erlandson et al. CLINICAL INFECTIOUS DISEASES
- Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms
- (2014) Andreas Bitter et al. ARCHIVES OF TOXICOLOGY
- Resveratrol as an Inhibitor of Pregnane X Receptor (PXR): Another Lesson in PXR Antagonism
- (2014) Tomas Smutny et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Resveratrol Suppresses the Inducible Expression of CYP3A4 Through the Pregnane X Receptor
- (2014) Rongrong Deng et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Liver cirrhosis
- (2014) Emmanuel A Tsochatzis et al. LANCET
- Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation
- (2014) Soo Jin Yang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study
- (2014) Barbara Sjouke et al. Lancet Diabetes & Endocrinology
- Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease
- (2013) Lake Li et al. FOOD AND CHEMICAL TOXICOLOGY
- Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation
- (2013) João Marcus Oliveira Andrade et al. NUTRITION
- Role of CAR and PXR in xenobiotic sensing and metabolism
- (2012) Yue-Ming Wang et al. Expert Opinion on Drug Metabolism & Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started